Alps Advisors Inc Galapagos Nv Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Galapagos Nv stock. As of the latest transaction made, Alps Advisors Inc holds 49,898 shares of GLPG stock, worth $1.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

49,898

Previous 51,451 3.02%

Holding current value

$1.28 Million

Previous $1.27 Million 12.72%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$24.2 - $30.67 $37,582 - $47,630	-1,553 Reduced 3.02%	49,898 $1.44 Million
Q2 2024 Aug 13, 2024	BUY	$24.78 - $32.48 $117,432 - $153,922	4,739 Added 10.15%	51,451 $1.27 Million
Q1 2024 May 14, 2024	BUY	$32.2 - $42.44 $31,878 - $42,015	990 Added 2.17%	46,712 $1.5 Million
Q4 2023 Feb 14, 2024	SELL	$31.87 - $40.71 $82,543 - $105,438	-2,590 Reduced 5.36%	45,722 $1.86 Million
Q3 2023 Nov 14, 2023	BUY	$34.17 - $42.98 $6,526 - $8,209	191 Added 0.4%	48,312 $1.67 Million
Q2 2023 Aug 14, 2023	BUY	$37.4 - $44.52 $189,468 - $225,538	5,066 Added 11.77%	48,121 $1.96 Million
Q1 2023 May 10, 2023	SELL	$36.5 - $48.0 $57,706 - $75,888	-1,581 Reduced 3.54%	43,055 $1.66 Million
Q4 2022 Feb 14, 2023	BUY	$37.44 - $46.51 $315,731 - $392,218	8,433 Added 23.29%	44,636 $1.98 Million
Q3 2022 Nov 14, 2022	SELL	$42.27 - $57.6 $125,161 - $170,553	-2,961 Reduced 7.56%	36,203 $1.54 Million
Q2 2022 Aug 11, 2022	SELL	$52.3 - $71.59 $1.46 Million - $2 Million	-27,998 Reduced 41.69%	39,164 $2.19 Million
Q1 2022 May 16, 2022	SELL	$51.32 - $68.5 $467,935 - $624,583	-9,118 Reduced 11.95%	67,162 $4.17 Million
Q4 2021 Feb 09, 2022	BUY	$47.03 - $57.12 $3.59 Million - $4.36 Million	76,280 New	76,280 $4.21 Million
Q2 2019 Aug 07, 2019	SELL	$111.45 - $128.93 $9.71 Million - $11.2 Million	-87,116 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$89.61 - $117.78 $989,742 - $1.3 Million	11,045 Added 14.52%	87,116 $10.3 Million
Q4 2018 Feb 04, 2019	SELL	$87.81 - $110.65 $1.3 Million - $1.64 Million	-14,777 Reduced 16.27%	76,071 $6.98 Million
Q3 2018 Oct 25, 2018	BUY	$90.63 - $120.22 $1.58 Million - $2.1 Million	17,459 Added 23.79%	90,848 $10.2 Million
Q2 2018 Aug 02, 2018	BUY	$88.4 - $105.34 $1.51 Million - $1.8 Million	17,079 Added 30.33%	73,389 $6.77 Million
Q2 2018 Jul 25, 2018	SELL	$88.4 - $105.34 $1.05 Million - $1.25 Million	-11,845 Reduced 17.38%	56,310 $5.28 Million
Q1 2018 May 01, 2018	BUY	$94.51 - $120.23 $1.12 Million - $1.42 Million	11,845 Added 21.04%	68,155 $6.8 Million
Q4 2017 Feb 05, 2018	BUY	$84.48 - $104.02 $529,267 - $651,685	6,265 Added 12.52%	56,310 $5.28 Million
Q3 2017 Nov 03, 2017	BUY	$73.17 - $103.47 $3.66 Million - $5.18 Million	50,045	50,045 $5.09 Million

Others Institutions Holding GLPG

# of Institutions

Shares Held

12.3M

Call Options Held

69.1K

Put Options Held

42.7K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.69B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Galapagos Nv Transaction History